These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 18227822

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sodium channels contribute to microglia/macrophage activation and function in EAE and MS.
    Craner MJ, Damarjian TG, Liu S, Hains BC, Lo AC, Black JA, Newcombe J, Cuzner ML, Waxman SG.
    Glia; 2005 Jan 15; 49(2):220-9. PubMed ID: 15390090
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Painful research: identification of a small-molecule inhibitor that selectively targets Nav1.8 sodium channels.
    Rush AM, Cummins TR.
    Mol Interv; 2007 Aug 15; 7(4):192-5, 180. PubMed ID: 17827438
    [Abstract] [Full Text] [Related]

  • 6. Ions, energy and axonal injury: towards a molecular neurology of multiple sclerosis.
    Waxman SG.
    Trends Mol Med; 2006 May 15; 12(5):192-5. PubMed ID: 16574486
    [Abstract] [Full Text] [Related]

  • 7. Axonal protection in multiple sclerosis--a particular need during remyelination?
    Smith KJ.
    Brain; 2006 Dec 15; 129(Pt 12):3147-9. PubMed ID: 17132643
    [No Abstract] [Full Text] [Related]

  • 8. A channelopathy contributes to cerebellar dysfunction in a model of multiple sclerosis.
    Shields SD, Cheng X, Gasser A, Saab CY, Tyrrell L, Eastman EM, Iwata M, Zwinger PJ, Black JA, Dib-Hajj SD, Waxman SG.
    Ann Neurol; 2012 Feb 15; 71(2):186-94. PubMed ID: 22367990
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sodium channel blockers and neuroprotection in multiple sclerosis using lamotrigine.
    Kapoor R.
    J Neurol Sci; 2008 Nov 15; 274(1-2):54-6. PubMed ID: 18486153
    [Abstract] [Full Text] [Related]

  • 11. Can clinical outcomes be used to detect neuroprotection in multiple sclerosis?
    Khan O.
    Neurology; 2007 May 29; 68(22 Suppl 3):S64-71; discussion S91-6. PubMed ID: 17548572
    [Abstract] [Full Text] [Related]

  • 12. Endogenous neuroprotection in multiple sclerosis.
    Gonsette RE.
    Acta Neurol Belg; 2010 Mar 29; 110(1):26-35. PubMed ID: 20514924
    [Abstract] [Full Text] [Related]

  • 13. Sodium channel blockers as neuroprotectants in neuroinflammatory disease: a double-edged sword.
    Stys PK.
    Ann Neurol; 2007 Jul 29; 62(1):3-5. PubMed ID: 17661358
    [No Abstract] [Full Text] [Related]

  • 14. [Sodium channels and multiple sclerosis].
    Colotto M, Danese C.
    Clin Ter; 2004 Jun 29; 155(6):245-8. PubMed ID: 15560285
    [Abstract] [Full Text] [Related]

  • 15. Na+ channel expression along axons in multiple sclerosis and its models.
    Waxman SG, Craner MJ, Black JA.
    Trends Pharmacol Sci; 2004 Nov 29; 25(11):584-91. PubMed ID: 15491781
    [Abstract] [Full Text] [Related]

  • 16. Neuroprotection and repair by neurotrophic and gliotrophic factors in multiple sclerosis.
    Loeb JA.
    Neurology; 2007 May 29; 68(22 Suppl 3):S38-42; discussion S43-54. PubMed ID: 17548567
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hitting a nerve: ion channels may hold the key for treating chronic pain.
    Shekhar C.
    Chem Biol; 2009 Oct 30; 16(10):1022-3. PubMed ID: 19875073
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Advancement of therapies for neuroprotection in multiple sclerosis.
    Lo A.
    Expert Rev Neurother; 2008 Sep 30; 8(9):1355-66. PubMed ID: 18759548
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.